Pipeline

Our diverse pipeline includes innovative therapeutics and biobetters.
We focus on three key therapeutic areas: orphans, cancers and immune disorders.

ORPHAN

Pipeline Compound Indication Research Pre-Clinical Clinical Phase
I II III
GX-H9 Long-Acting hGH Adult Growth Hormone Deficiency
 
 
Pediatric Growth Hormone Deficiency
 
 
GX-G8 GLP-2 Short Bowel Syndrome
 
 
GX-30 Thyroid-Stimulating Hormone (TSH) A diagnostic agent for the follow-up of patients with thyroid cancer
 
 

CANCER

Pipeline Compound Indication Research Pre-Clinical Clinical Phase
I II III
GX-188E DNA Therapeutic Vaccine Cervical Intraepithelial Neoplasia 3
 
 
Cervical Intraepithelial Neoplasia 2/3
 
 
Cervical Cancer Trial with Checkpoint Inhibitor (CPI)
 
 
GX-I7 IL-7 Persistent HPV
Infections
 
 
Lymphopenia
 
 
Solid Tumors
 
 
GX-G8 GLP-2 Chemotherapy-Induced Diarrhea
 
 

IMMUNE DISORDER

Pipeline Compound Indication Research Pre-Clinical Clinical Phase
I II III
GX-P2 PD-L1 Inflammatory Bowel Disease
 
 
Psoriasis
 
 

BIOBETTER PROGRAM

Pipeline Compound Indication Research Pre-Clinical Clinical Phase
I II III
GX-E2 EPO Anemia
 
 
GX-G3 G-CSF Neutropenia
 
 
GX-G6 GLP-1 Diabetes